Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • Aster DM Healthcare Q4...

    Aster DM Healthcare Q4 net profit up 7.1 percent to Rs 219.84 crore

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-05-31T09:30:44+05:30  |  Updated On 31 May 2019 9:30 AM IST
    Aster DM Healthcare Q4 net profit up 7.1 percent to Rs 219.84 crore

    "We are very happy to report strong growth at both the top line and EBITDA (Earnings before interest, tax, depreciation and amortisation) level. All hospitals in the GCC and India are performing well and new hospitals in India are also doing better than expected," Aster DM Healthcare Chairman Azad Moopen said.


    New Delhi: Healthcare services provider Aster DM Healthcare on May 27 reported a 7.12 per cent increase in consolidated net profit at Rs 219.84 crore for the fourth quarter ended March 2019.


    The company had posted a net profit of Rs 205.22 crore in January-March 2018, Aster DM Healthcare said in a filing to the BSE.


    Total income during the March quarter stood at Rs 2,208.50 crore, up 23.14 per cent, from Rs 1,793.41 crore in the year-ago quarter.


    Read Also: Aster DM Healthcare to infuse Rs 750 crore to add 1500 beds in four new hospitals


    "We are very happy to report strong growth at both the top line and EBITDA (Earnings before interest, tax, depreciation and amortisation) level. All hospitals in the GCC and India are performing well and new hospitals in India are also doing better than expected," Aster DM Healthcare Chairman Azad Moopen said.




    Total expenses during the latest quarter rose 22.20 per cent to Rs 1,983.91 crore against Rs 1,623.46 crore in the year-ago period.



    For the financial year 2018-19, net profit increased 30.39 per cent to Rs 367.31 crore from Rs 281.69 crore in 2017-18.

    Total income for the last fiscal stood at Rs 7,997.33 crore, up 18.18 per cent as compared with Rs 6,766.60 crore in the previous year.

    Read Also: Moopen backed Aster DM to infuse about Rs 1000 crore in Indian Hospitals by 2021: Report


    amortisationAster DMAster DM Healthcareaster dm Q4Azad MoopenBSEconsolidated net profitDM Healthcare net profitEBITDAfourth quarterGCCHealthcareIndiaShares of Aster DM Healthcaretax depreciation
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok